[HTML][HTML] Investigation of inflammation in Lewy body dementia: a systematic scoping review

PM Loveland, JJ Yu, L Churilov, N Yassi… - International Journal of …, 2023 - mdpi.com
Inflammatory mechanisms are increasingly recognized as important contributors to the
pathogenesis of neurodegenerative diseases, including Lewy body dementia (LBD). Our …

[HTML][HTML] Clinical biomarkers for Lewy body diseases

MM Abdelmoaty, E Lu, R Kadry, EG Foster, S Bhattarai… - Cell & Bioscience, 2023 - Springer
Synucleinopathies are a group of neurodegenerative disorders characterized by pathologic
aggregates of neural and glial α-synuclein (α-syn) in the form of Lewy bodies (LBs), Lewy …

Mediator complex in neurological disease

C Schiano, L Luongo, S Maione, C Napoli - Life Sciences, 2023 - Elsevier
Neurological diseases, including traumatic brain injuries, stroke (haemorrhagic and
ischemic), and inherent neurodegenerative diseases cause acquired disability in humans …

[HTML][HTML] Protein biomarkers shared by multiple neurodegenerative diseases are calmodulin-binding proteins offering novel and potentially universal therapeutic …

DH O'Day - Journal of Clinical Medicine, 2023 - mdpi.com
Seven major neurodegenerative diseases and their variants share many overlapping
biomarkers that are calmodulin-binding proteins: Alzheimer's disease (AD), amyotrophic …

Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and …

Y Hirschberg, N Valle‐Tamayo… - Journal of …, 2023 - Wiley Online Library
Dementia is a leading cause of death worldwide, with increasing prevalence as global life
expectancy increases. The most common neurodegenerative disorders are Alzheimer's …

[HTML][HTML] Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with …

Z Tang, S Hirano, Y Koizumi, M Izumi… - Journal of …, 2024 - content.iospress.com
Background: Dementia with Lewy bodies (DLB) presents with various symptoms, posing
challenges for early diagnosis challenging. Dopamine transporter (123 I-FP-CIT) single …

Utility of combining multiple parameters of 123I-IMP SPECT and voxel-based morphometry MRI using a multiparametric scoring system for differentiating dementia …

E Matsusue, C Inoue, M Shimoda… - Acta …, 2024 - journals.sagepub.com
Background Brain magnetic resonance imaging voxel-based morphometry (VBM) and
perfusion single-photon emission computed tomography (SPECT) are useful for …

Combined 18F‐FDG PET‐CT markers in dementia with Lewy bodies

MV Mattoli, F Cocciolillo… - Alzheimer's & …, 2023 - Wiley Online Library
Abstract INTRODUCTION 18F‐Fluoro‐deoxyglucose–positron emission tomography (FDG‐
PET) is a supportive biomarker in dementia with Lewy bodies (DLB) diagnosis and its …

The role of 123-I-MIBG cardiac scintigraphy in the differential diagnosis between dementia with Lewy bodies and Alzheimer's disease

G Monzio Compagnoni, I Appollonio, C Ferrarese - Neurological Sciences, 2024 - Springer
Although detailed diagnostic guidelines are available, differentiating dementia with Lewy
bodies from Alzheimer's disease is often difficult. 123-I-MIBG cardiac scintigraphy is one of …

Differences in retinal and choroidal microvasculature and structure in dementia with lewy bodies compared with normal cognition

S Joseph, CB Robbins, A Allen… - Journal of …, 2024 - journals.sagepub.com
Purpose: To evaluate the retinal and choroidal microvasculature and structure in individuals
with dementia with Lewy bodies (DLB) compared with controls with normal cognition using …